Delivery Order SPE2DB24D1007-SPE2DB25FCBRQ
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $15,064.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of the prescription medication Rexulti 1 mg tablet, with an ultimate completion date of May 6, 2025. The contract is not set aside and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,606.39 firm fixed-price delivery order is for the supply of 4,566,121,371 units of the prescription drug Rexulti 2 mg tablet. The contract has an ultimate completion date of October 17, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,055.93 firm fixed-price delivery order is for the supply of Rexulti 1 mg tablets, a prescription medication. The contract has a completion date of February 21, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical and medical supply distributor. The $9,342.25 delivery order is for the supply of Rexulti 1 mg tablets, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 and spanning through December 2025. This IDC enables DLA to efficiently...
This federal contract award, valued at $16,730.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Rexulti 0.5 mg tablet, with an ultimate completion date of April 30, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $30,591.65, is for the supply of Rexulti 1 mg tablets, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military...
This federal contract award, valued at $9,219.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order of the prescription medication Rexulti 1 mg tablet, with an ultimate completion date of April 23, 2025. This contract is not designated as a set-aside and is a firm fixed-price contract. Additionally, AmerisourceBergen Drug Corp holds a substantial Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,533.64 firm fixed-price delivery order is for the drug Rexulti 1 mg Tablet 30s and has a completion date of February 6, 2025. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide...
This federal contract award, valued at $27,845.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the prescription drug Rexulti 1 mg tablets. The contract is a firm fixed-price Delivery Order (DO) with a period of performance through September 6, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $4,989.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the medical product Rexulti 1 mg Tablet 30s, a prescription medication. The contract has an ultimate completion date of January 13, 2025 and uses a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...